Pricing Log in Create free account

Longeveron Inc. (LGVN) vs Heatwurx Inc. (PCSA)

Longeveron Inc. and Heatwurx Inc. are both Biotechnology companies. Longeveron Inc. and Heatwurx Inc. are of similar size ($4.8M and $4.7M). Longeveron Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.6×. Heatwurx Inc. grew revenue faster over the last twelve months: −34.5% against −42.7%. Heatwurx Inc. has the higher net margin (0.00% vs −1,977.6%) and the higher return on invested capital (0.00% vs −4,549.0%). Across the 15 metrics below, Heatwurx Inc. leads on 8 and Longeveron Inc. on 7.

Valuation

Metric LGVN PCSA Biotechnology median
P/E n/m 1.61 8.50
P/S 3.67 35.49 9.71
P/B 0.42 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.22 n/m 0.64
EV/Sales (4.16) 45.29 9.21
Earnings yield (712.23%) 62.21% (33.15%)
Free cash flow yield (477.81%) (282.73%) (25.50%)

Profitability

Metric LGVN PCSA Biotechnology median
Gross margin 69.76% 0.00% 65.16%
Operating margin (1,992.84%) 0.00% 0.00%
Net margin (1,977.59%) 0.00% 0.00%
Free cash flow margin (1,755.69%) 0.00% 0.00%
Return on equity (203.61%) (464.19%) (56.36%)
Return on assets (145.64%) (262.17%) (48.04%)
Return on invested capital (4,549.04%) 0.00% 0.00%

Growth

Metric LGVN PCSA Biotechnology median
Revenue growth (TTM) (42.74%) (34.50%) 6.02%
EPS growth (last fiscal year) 50.76% 89.29% 30.26%
Revenue growth, 5-year CAGR (26.60%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LGVN PCSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.63 0.87 4.72
Net debt to EBITDA 0.20 0.40 0.96

Dividend

Metric LGVN PCSA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LGVN PCSA Biotechnology median
Market cap 4.79m 4.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack